FDA Authorizes Booster for Children 5-11

FDA Expands Eligibility for Pfizer Vaccine Booster Dose to Children 5-11

On May 17th, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for individuals 5 to 11 years of age. The booster dose must come at least five months after completion of a primary series with the Pfizer-BioNTech COVID-19 Vaccine. The first dose of the vaccine was approved for children 5 and up in October of 2021. For more information on the release of the booster dose, check out this article from iHeart radio.

Find more information on the release of the booster dose, data supporting its effectiveness, and safety evaluation information in the news release from the FDA.